260660 — Korea Arlico Pharm Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Korea Arlico Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	—	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	28,747	32,203	30,790	19,194	20,993
Net Total Accounts Receivable
Net Total Receivables	19,379	19,997	22,536	30,352	28,093
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	68,855	82,123	83,555	85,334	82,902
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	31,641	49,726	66,740	63,152	61,994
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	121,062	153,536	173,477	172,363	171,844
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	33,770	57,258	70,320	75,195	73,966
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	39,933	64,990	84,402	92,684	93,641
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	81,129	88,546	89,075	79,679	78,203
Total Liabilities & Shareholders' Equity	121,062	153,536	173,477	172,363	171,844
Total Common Shares Outstanding